337 related articles for article (PubMed ID: 26614015)
1. Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb.
Garg N; Singh R; Shukla G; Capalash N; Sharma P
Int J Med Microbiol; 2016 Jan; 306(1):1-9. PubMed ID: 26614015
[TBL] [Abstract][Full Text] [Related]
2. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii.
Huang W; Yao Y; Wang S; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Chu X; Bai H; Yao Y; Ma Y
Sci Rep; 2016 Feb; 6():20724. PubMed ID: 26853590
[TBL] [Abstract][Full Text] [Related]
3. OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections.
Huang W; Wang S; Yao Y; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Ma Y
Vaccine; 2015 Aug; 33(36):4479-85. PubMed ID: 26207591
[TBL] [Abstract][Full Text] [Related]
4. Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii.
Singh R; Capalash N; Sharma P
Sci Rep; 2017 Sep; 7(1):12411. PubMed ID: 28963492
[TBL] [Abstract][Full Text] [Related]
5. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice.
KuoLee R; Harris G; Yan H; Xu HH; Conlan WJ; Patel GB; Chen W
Vaccine; 2015 Jan; 33(1):260-7. PubMed ID: 24699469
[TBL] [Abstract][Full Text] [Related]
6. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Protective Efficacy of a Fused OmpK/Omp22 Protein Vaccine Candidate against Acinetobacter baumannii Infection in Mice.
Guo SJ; Ren S; Xie YE
Biomed Environ Sci; 2018 Feb; 31(2):155-158. PubMed ID: 29606195
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic Resistance Determinant-Focused Acinetobacter baumannii Vaccine Designed Using Reverse Vaccinology.
Ni Z; Chen Y; Ong E; He Y
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230771
[TBL] [Abstract][Full Text] [Related]
9. In Silico Design and Evaluation of Acinetobacter baumannii Outer Membrane Protein a Antigenic Peptides As Vaccine Candidate in Immunized Mice.
Mehdinejadiani K; Bandehpour M; Hashemi A; Ranjbar MM; Taheri S; Jalali SA; Mosaffa N
Iran J Allergy Asthma Immunol; 2019 Nov; 18(6):655-663. PubMed ID: 32245309
[TBL] [Abstract][Full Text] [Related]
10. Exploitation of two siderophore receptors, BauA and BfnH, for protection against Acinetobacter baumannii infection.
Aghajani Z; Rasooli I; Mousavi Gargari SL
APMIS; 2019 Dec; 127(12):753-763. PubMed ID: 31512768
[TBL] [Abstract][Full Text] [Related]
11. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.
Luo G; Lin L; Ibrahim AS; Baquir B; Pantapalangkoor P; Bonomo RA; Doi Y; Adams MD; Russo TA; Spellberg B
PLoS One; 2012; 7(1):e29446. PubMed ID: 22253723
[TBL] [Abstract][Full Text] [Related]
12. Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii.
Zhang X; Yang T; Cao J; Sun J; Dai W; Zhang L
Microb Pathog; 2016 Jul; 96():20-5. PubMed ID: 27133268
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection.
Ainsworth S; Ketter PM; Yu JJ; Grimm RC; May HC; Cap AP; Chambers JP; Guentzel MN; Arulanandam BP
Vaccine; 2017 Jun; 35(26):3387-3394. PubMed ID: 28522011
[TBL] [Abstract][Full Text] [Related]
14. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.
McConnell MJ; Rumbo C; Bou G; Pachón J
Vaccine; 2011 Aug; 29(34):5705-10. PubMed ID: 21679737
[TBL] [Abstract][Full Text] [Related]
15. In silico design of an immunogen against Acinetobacter baumannii based on a novel model for native structure of Outer membrane protein A.
Jahangiri A; Rasooli I; Owlia P; Fooladi AA; Salimian J
Microb Pathog; 2017 Apr; 105():201-210. PubMed ID: 28242426
[TBL] [Abstract][Full Text] [Related]
16. New putative vaccine candidates against Acinetobacter baumannii using the reverse vaccinology method.
Fereshteh S; Abdoli S; Shahcheraghi F; Ajdary S; Nazari M; Badmasti F
Microb Pathog; 2020 Jun; 143():104114. PubMed ID: 32145321
[TBL] [Abstract][Full Text] [Related]
17. Prevention of nosocomial Acinetobacter baumannii infections with a conserved immunogenic fimbrial protein.
Mahmoudi Z; Rasooli I; Jahangiri A; Darvish Alipour Astaneh S
APMIS; 2020 Jul; 128(7):476-483. PubMed ID: 32445596
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analysis and epitope screening of a potential vaccine antigen TolB from Acinetobacter baumannii outer membrane protein.
Song X; Zhang H; Zhang D; Xie W; Zhao G
Infect Genet Evol; 2018 Aug; 62():73-79. PubMed ID: 29673984
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of a multi-epitope assembly peptide vaccine against Acinetobacter baumannii infection in mice.
Ren S; Guan L; Dong Y; Wang C; Feng L; Xie Y
Swiss Med Wkly; 2019 Jun; 149():w20052. PubMed ID: 31203576
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology.
Chiang MH; Sung WC; Lien SP; Chen YZ; Lo AF; Huang JH; Kuo SC; Chong P
Hum Vaccin Immunother; 2015; 11(4):1065-73. PubMed ID: 25751377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
